Manchester Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-133
Closed -$1.65K 951
2023
Q1
$1.65K Buy
133
+26
+24% +$478 ﹤0.01% 830
2022
Q4
$2.06K Hold
107
﹤0.01% 694
2022
Q3
$2K Buy
107
+21
+24% +$432 ﹤0.01% 624
2022
Q2
$2K Buy
+86
New +$1.4K ﹤0.01% 671

Other funds holding AHCO

Manchester Capital Management's AHCO Position: Q2 2023 in Review

Manchester Capital Management sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 133 shares — an estimated $1.65K sold.

Manchester Capital Management first reported a position in AHCO in Q2 2022 and held it in 4 quarters. The position peaked at $2.06K in Q4 2022. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • Manchester Capital Management reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • Manchester Capital Management sold 133 AdaptHealth shares in Q2 2023, an estimated $1.65K.
  • Manchester Capital Management first reported a position in AdaptHealth in Q2 2022 and held it in 4 quarters.
  • Manchester Capital Management's AdaptHealth position peaked at $2.06K in Q4 2022.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Manchester Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.